2024 HCPCS Code J0873
Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg
TAGS: equivalent daptomycin j0878 therapeutically
| Short Description | Inj daptomycin (xellia) |
| HCPCS Coverage Code | C - Carrier judgment |
| HCPCS Action Code | C - Change in long description of procedure or modifier code |
| HCPCS Action Effective Date | July 01, 2024 |
| HCPCS Code Added Date | January 01, 2024 |
| HCPCS Pricing Indicator Code | 51 - Drugs |
| HCPCS Multiple Pricing Indicator Code | A - Not applicable as HCPCS priced under one methodology |
| HCPCS Coverage Issues Manual Reference Section Number | |
| HCPCS Type Of Service Code | 1 - Medical care |
| HCPCS Anesthesia Base Unit Quantity | 0 |
Check Similar HCPCS Codes
- J9268 - Pentostatin injection
- J9269 - Inj. tagraxofusp-erzs 10 mcg
- J9270 - Plicamycin (mithramycin) inj
- J9271 - Inj pembrolizumab
- J9272 - Inj, dostarlimab-gxly, 10 mg
- J9273 - Inj tisotu vedotin-tftv, 1mg
- J9274 - Inj, tebentafusp-tebn, 1 mcg
- J9280 - Mitomycin injection
- J9281 - Mitomycin instillation
- J9285 - Inj, olaratumab, 10 mg
- J9286 - Inj glofitamab gxbm, 2.5 mg
- J9293 - Mitoxantrone hydrochl / 5 mg
- J9294 - Inj pemetrexed, hospira 10mg
- J9295 - Injection, necitumumab, 1 mg
- J9296 - Inj pemetrexed (accord) 10mg
- J9297 - Inj pemetrexed (sandoz) 10mg
- J9298 - Inj nivol relatlimab 3mg/1mg
- J9299 - Injection, nivolumab
- J9300 - Gemtuzumab ozogamicin inj
- J9301 - Obinutuzumab inj